In August 2025, global Aspirin prices saw a gentle dip after seeing a hike in prices last month. Supportive demand, sufficient supply, and prudent consumerism under fear of rising inflation fears in major markets such as Germany and the USA are reasons behind the price correction. The medium-term is cautiously upbeat with possible price stabilization and restocking towards the tail end of 2025.
Key Highlights:
-
The price of Aspirin decreased marginally in August following a July rise.
-
China continues to be the largest exporter of Aspirin APIs into Western markets.
-
Buyers have stocked up, lessening the need for prompt purchasing.
-
The rate of inflation in Germany crept up to x.xx, triggering prudent consumer spending.
-
US demand was flat during an extension of the US-China trade agreement.
-
China&#xx;s October Golden Week might lead to short-term supply tightening.
-
Cold winter months are to drive pharmaceutical demand.
-
Short-term vision foresees market stabilization and potential price recovery towards the end of xxxx.
In August xxxx, the global Aspirin market experienced a minor price fall following a minor price rise last month. This shows harmony between steady downstream demand and sufficient supply quantities. China is still the biggest exporter of Aspirin APIs to Western countries such as the USA and Germany. Most of the overseas buyers had pre-stocked their inventories in advance and...
